Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Springhorn Jeremy P. Create: Alert

All | News | Filings
Date FiledTypeDescription
03/01/2023 4 Springhorn Jeremy P. (Director) has filed a Form 4 on uniQure N.V.
Txns: Sold 384 shares @ $20.41, valued at $7.8k
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/30/2020 4 Springhorn Jeremy P. (Director) has filed a Form 4 on uniQure N.V.
Txns: Sold 4 shares @ $60.94, valued at $243.8
Sold 803 shares @ $62.2, valued at $49.9k
11/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/30/2019 4 Springhorn Jeremy P. (Director) has filed a Form 4 on uniQure N.V.
Txns: Sold 1,210 shares @ $31.32, valued at $37.9k
01/29/2019 4 Springhorn Jeremy P. (Director) has filed a Form 4 on uniQure N.V.
Txns: Granted 3,230 shares @ $0
Granted 5,295 options to buy @ $31.71, valued at $167.9k
01/30/2018 4 Springhorn Jeremy P. (Director) has filed a Form 4 on uniQure N.V.
Txns: Granted 4,792 shares @ $0
Granted 6,390 options to buy @ $19.39, valued at $123.9k
12/15/2017 4 Springhorn Jeremy P. (Chief Business Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Bought 15,000 shares @ $9.084, valued at $136.3k
11/14/2017 4 Springhorn Jeremy P. (Chief Business Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 150,000 options to buy @ $11.65, valued at $1.7M
Granted 50,000 options to buy @ $11.65, valued at $582.5k
11/14/2017 3 Springhorn Jeremy P. (Chief Business Officer) has filed a Form 3 on Syros Pharmaceuticals, Inc.
09/26/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/26/2017 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy